Effect of mask dead space and occlusion of mask holes on delivery of nebulized albuterol

Respiratory Care

Volumn 59, Issue 8, 2014, Pages 1228-1232

  Berlinski, Ariel ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Albuterol; Breathing patterns; Face mask; In vitro; Mask dead space; Nebulizer

Indexed keywords

SALBUTAMOL; AEROSOL; BRONCHODILATING AGENT;

ARTICLE; BREATHING RATE; EXPIRATORY FLOW; FACE MASK; HUMAN; INSPIRATORY CAPACITY; MEDICAL DEVICE COMPLICATION; NEBULIZER; OCCLUSION; TIDAL VOLUME; ADULT; AEROSOL; BIOLOGICAL MODEL; BREATHING; CHILD; COMPARATIVE STUDY; EQUIPMENT DESIGN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG DEAD SPACE; MASK;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; CHILD; EQUIPMENT DESIGN; HUMANS; INFANT; MASKS; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; RESPIRATION; RESPIRATORY DEAD SPACE; TIDAL VOLUME;

EID: 84928118573     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02978     Document Type: Article

References (14)

1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995, 332(3): 133-138.
2. Schweich PJ, Smith KM, Dowd MD, Walkley El. Pediatric emergency medicine practice patterns: a comparison of pediatric and general emergency physicians. Pediatr Emerg Care 1998; 14(2): 89-94.
3. McCulloh RJ, Smitherman SE, Koehn KL, Alverson BK. Assessing the impact of national guidelines on the management of children hospitalized for acute bronchiolitis. Pediatr Pulmonol 2013 [Epub ahead of print] doi: 10. 1002/ppul. 22835.
4. Mellon M, Leflein J, Walton-Bowen K, Cruz-Rivera M, Fitzpatrick S, Smith JA. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med 2000; 162(2 Pt 1): 593-598.
5. Georgitis JW, McWilliams B, Cruz-Rivera M, Fitzpatrick S, Smith JA. Effective once-daily administration of budesonide inhalation sus pension by nebulizer with facemasks or mouthpieces for persistent asthma in infants and young children. Pediatr Asthma Allergy Immunol 2001; 15(1): 3-13.
6. Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 1992; 14(3): 192-196.
7. Kishida M, Suzuki I, Kabayama H, Koshibu T, Izawa M, Takeshita Y, et al. Mouthpiece versus facemask for delivery of nebulized sal-butamol in exacerbated childhood asthma. J Asthma 2002; 39(4): 337-339.
8. Sangwan S, Gurses BK, Smaldone GC. Facemasks and facial deposition of aerosols. Pediatr Pulmonol 2004; 37(5): 447-452.
9. Geller DE. Clinical side effects during aerosol therapy: cutaneous and ocular effects. J Aerosol Med 2007; 20(Suppl 1): S 100-S108; discussion S109.
10. Chavez A, McCracken A, Berlinski A. Effect of face mask dead volume, respiratory rate, and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010; 45(3): 224-229.
11. Shah SA, Berlinski AB, Rubin BK. Force-dependent static dead space of face masks used with holding chambers. Respir Care 2006; 51(2): 140-144.
12. 2 retention and rebreathing of a facemask designed for efficient delivery of aerosols to infants. 1SRN Pediatr 2012; 2012: 721295.
13. Bauer A, McGlynn P, Bovet LL, Mims PL, Curry LA, Hanrahan JP-The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulator. Respir Care 2009; 54(11): 1488-1492.
14. Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv 2008; 5(2): 114-119.